NUVB profile · all as-reported value updates
Nuvation Bio Inc. (NUVB) as-reported value updates
Descriptive filing record — not investment advice. This page compares two SEC XBRL-filed values for the same fiscal period. It does not state why the values differ and is not a rating, score, or recommendation. See Disclaimer.
Reported values for the same fiscal period can differ between filings for many routine reasons: re-presentation for discontinued operations, adoption of new accounting standards, reclassifications, changes in rounding precision, and amendments. This ledger records that the filed values differ; it does not and cannot determine why. Both filings are linked below so the reader can consult the source.
Ledger table figure
| Metric | FY | Earliest XBRL-filed value | Currently on file | Difference | Difference % | Label | Filing links | Notes |
|---|---|---|---|---|---|---|---|---|
| Stockholders' equity | 2020 | 5,000,006 | 215,084,000 | 210,083,994 | +97.68% | revised comparative figure | 0001193125-21-077880 0000950170-23-008180 | 4 filed observations examined for this concept and period. |
| Cash and cash equivalents | 2020 | 908,111 | 29,755,000 | 28,846,889 | +96.95% | revised comparative figure | 0001193125-21-077880 0000950170-22-002332 | 3 filed observations examined for this concept and period. |
| Liabilities | 2020 | 2,798,715 | 6,708,000 | 3,909,285 | +58.28% | revised comparative figure | 0001193125-21-077880 0000950170-22-002332 | 3 filed observations examined for this concept and period. |
| Assets | 2020 | 145,004,211 | 221,792,000 | 76,787,789 | +34.62% | revised comparative figure | 0001193125-21-077880 0000950170-22-002332 | 3 filed observations examined for this concept and period. |